CIVI BIOPHARMA Trademark

Trademark Overview

On Friday, February 16, 2018, a trademark application was filed for CIVI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CIVI BIOPHARMA trademark a serial number of 87801002. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 22, 2020. This trademark is owned by CiVi Biopharma, Inc.. The CIVI BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; research and development in the field of cardiology
civi biopharma

General Information

Serial Number87801002
Word MarkCIVI BIOPHARMA
Filing DateFriday, February 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 22, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; research and development in the field of cardiology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCiVi Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBryn Mawr, PA 19010
Party NameCiVi Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBryn Mawr, PA 19010

Trademark Events

Event DateEvent Description
Monday, June 22, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 22, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 3, 2020CORRECTED NOA E-MAILED
Monday, March 2, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, January 29, 2020DIVISIONAL REQUEST RECEIVED
Monday, March 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 29, 2020TEAS REQUEST TO DIVIDE RECEIVED
Friday, November 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2019EXTENSION 2 GRANTED
Wednesday, November 20, 2019EXTENSION 2 FILED
Wednesday, November 20, 2019TEAS EXTENSION RECEIVED
Tuesday, May 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2019EXTENSION 1 GRANTED
Friday, May 17, 2019EXTENSION 1 FILED
Friday, May 17, 2019TEAS EXTENSION RECEIVED
Monday, February 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 23, 2018ASSIGNED TO LIE
Monday, July 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 5, 2018NON-FINAL ACTION E-MAILED
Tuesday, June 5, 2018NON-FINAL ACTION WRITTEN
Friday, June 1, 2018ASSIGNED TO EXAMINER
Saturday, February 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 20, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharma civi research development field cardiology biotechnology pharmaceutical fields